160 HEALTH (02656) has surged more than 8% during trading, reaching a new high of HKD 42.34, which is over 256% higher than its IPO price of HKD 11.89. As of the time of writing, the stock has increased by 5.84%, priced at HKD 41.32, with a transaction volume of HKD 31.825 million. 160 HEALTH was listed on September 17, 2023. According to its prospectus, the company is an experienced wholesaler of Chinese pharmaceutical and health products as well as a leading digital health service provider. It offers a wide range of pharmaceutical and health products along with comprehensive digital health solutions. Additionally, the company provides digital healthcare solutions through its online platform—160 HEALTH, empowering participants across the healthcare industry chain. As of March 31, 2025, the platform has connected over 44,600 healthcare institutions since its establishment, including more than 14,400 hospitals (among which 3,430 are tertiary hospitals) and over 30,200 primary healthcare institutions. Among the healthcare institutions partnered with the company, over 6,800 private entities primarily offer consumer medical services, such as dental, ophthalmology, and health check-ups, through the platform.